Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 1.26p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.05
  • 52 Week Low: 1.10
  • Currency: UK Pounds
  • Shares Issued: 979.75m
  • Volume: 1,324,055
  • Market Cap: £12.30m
  • RiskGrade: 340

Latest ShareCast News

Hemogenyx signs another deal with unnamed global pharma company

By Josh White

Date: Wednesday 23 Oct 2019

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

Hemogenyx enters collaboration agreement with Orgenesis

By Iain Gilbert

Date: Friday 19 Oct 2018

(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement with cell therapy outfit Orgenesis to further commercialise its humanised-mouse drug model.

Hemogenyx inks lupus collaboration with Johnson and Johnson

By Iain Gilbert

Date: Monday 15 Oct 2018

(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement industry giant Johnson and Johnson to develop a model of systemic lupus erythematosus, the most common form of Lupus.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.26p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.05
52 Week Low 1.10
Volume 1,324,055
Shares Issued 979.75m
Market Cap £12.30m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.28% above the market average3.28% above the market average3.28% above the market average3.28% above the market average3.28% above the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Price Trend
62.43% below the market average62.43% below the market average62.43% below the market average62.43% below the market average62.43% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 01-Dec-2022

Time Volume / Share Price
16:17 238 @ 1.25p
15:07 7,940 @ 1.25p
14:16 87,377 @ 1.25p
14:09 158 @ 1.25p
13:46 58,685 @ 1.25p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page